Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_assertion description "[Thus, our report reveals for the first time that sequential treatment of Aurora B inhibitors and cisplatin is essential to inhibit ovarian carcinoma by inducing polyploidy and downregulating c-Myc and that c-Myc is identified as a predictive biomarker to select cells responsive to chemotherapeutical combinations targeting Aurora B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_assertion evidence source_evidence_literature NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_assertion SIO_000772 25411027 NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_assertion wasDerivedFrom befree-2016 NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_assertion wasGeneratedBy ECO_0000203 NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.
- befree-2016 importedOn "2016-02-19" NP1238745.RAvOjwLg7g2hGt6cI5YHAxqEQk-EzdfqiHxNBIbHFmXpo130_provenance.